{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:46:00Z","timestamp":1791477960349,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.hrtlng.2026.102836","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:55:09Z","timestamp":1779238509000},"page":"102836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacological burden and chemical phlebitis associated with peripheral venous catheters: A nested case-control study. Results of the national Flebitis Zero project"],"prefix":"10.1016","volume":"79","author":[{"given":"Marta","family":"Ferraz-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Moreno-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3695-9216","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Cobo-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Mar\u00eda","family":"Alarc\u00f3n-Duque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Su\u00e1rez-Mier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Del Camino Del","family":"R\u00edo-Pisabarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Cernuda-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2026.102836_bib0001","series-title":"Clinical Practice Guideline on Intravenous Therapy with Non-Permanent Devices in Adults","year":"2014"},{"key":"10.1016\/j.hrtlng.2026.102836_bib0002","unstructured":"Ag\u00e8ncia de Qualitat i Avaluaci\u00f3 Sanit\u00e0ries de Catalunya (AQuAS). Unnecessary peripheral venous catheter [Technical Report]. Barcelona: AQuAS 2022 [date of citation: 16 january 2026] Available from: https:\/\/essencialsalut.gencat.cat\/web\/.content\/minisite\/essencial\/fitxes_cercador\/2022\/essencial_cateter_venoso_AQuAS2022es.pdf."},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102836_bib0003","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.12968\/bjon.2024.33.2.S12","article-title":"A safe and effective winged peripheral intravenous cannula for use in clinical practice","volume":"33","author":"Mu\u00f1oz-Mozas","year":"2024","journal-title":"Br J Nurs"},{"issue":"6","key":"10.1016\/j.hrtlng.2026.102836_bib0004","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.11124\/JBIES-23-00172","article-title":"Consumer experience and outcomes of insertion, removal, and management practices of short and midline peripheral intravenous catheters in acute health care: a mixed methods systematic review protocol","volume":"22","author":"Nelson","year":"2024","journal-title":"JBI Evid Synth"},{"key":"10.1016\/j.hrtlng.2026.102836_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2023.104673","article-title":"Peripheral intravenous catheter infection and failure: a systematic review and meta-analysis","volume":"151","author":"Marsh","year":"2024","journal-title":"Int J Nurs Stud"},{"issue":"12","key":"10.1016\/j.hrtlng.2026.102836_bib0006","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1111\/jan.14565","article-title":"Peripheral intravenous catheter non-infectious complications in adults: a systematic review and meta-analysis","volume":"76","author":"Marsh","year":"2020","journal-title":"J Adv Nurs"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102836_bib0007","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4037\/ccn2019790","article-title":"Peripheral intravenous access: applying infusion therapy standards of practice to improve patient safety","volume":"39","author":"Nickel","year":"2019","journal-title":"Crit Care Nurse"},{"issue":"3","key":"10.1016\/j.hrtlng.2026.102836_bib0008","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/1129729819877323","article-title":"The incidence and risk of infusion phlebitis with peripheral intravenous catheters: a meta-analysis","volume":"21","author":"Lv","year":"2020","journal-title":"J Vasc Access"},{"key":"10.1016\/j.hrtlng.2026.102836_bib0009","article-title":"Risk factors for peripheral intravenous catheter-related phlebitis in adult patients","volume":"56","author":"Sim\u00f5es","year":"2022","journal-title":"Rev da Esc Enferm"},{"issue":"3","key":"10.1016\/j.hrtlng.2026.102836_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.idh.2023.02.001","article-title":"Care bundle for the prevention of peripheral venous catheter blood stream infections at a secondary care university hospital: implementation and results","volume":"28","author":"Llad\u00f3 Maura","year":"2023","journal-title":"Infect Dis Heal"},{"key":"10.1016\/j.hrtlng.2026.102836_bib0011","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.hrtlng.2022.07.015","article-title":"A pilot randomized controlled trial of securement bundles to reduce peripheral intravenous catheter failure","volume":"57","author":"Corley","year":"2023","journal-title":"Hear Lung"},{"issue":"4","key":"10.1016\/j.hrtlng.2026.102836_bib0012","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jhin.2019.02.004","article-title":"Results of a multi-faceted educational intervention to prevent peripheral venous catheter-associated bloodstream infections","volume":"102","author":"Garcia-Gasalla","year":"2019","journal-title":"J Hosp Infect"},{"issue":"4","key":"10.1016\/j.hrtlng.2026.102836_bib0013","article-title":"Analysis of risk factors associated with phlebitis in peripheral venous catheters. Zero phlebitis project","volume":"35","author":"Ferraz-Torres","year":"2025","journal-title":"Enfermer\u00eda Cl\u00ednica (English Ed"},{"issue":"9","key":"10.1016\/j.hrtlng.2026.102836_bib0014","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/1469-0691.12049","article-title":"Impact of a multimodal intervention to reduce bloodstream infections related to vascular catheters in non-ICU wards: a multicentre study","volume":"19","author":"Freixas","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102836_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12959-021-00301-x","article-title":"Incidence of peripheral intravenous catheter phlebitis and its associated factors among patients admitted to university of gondar hospital, northwest ethiopia: a prospective, observational study","volume":"19","author":"Lulie","year":"2021","journal-title":"Thromb J"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102836_bib0016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13613-022-01009-5","article-title":"AMOR-NUS study group. Risk factors for peripheral intravascular catheter-related phlebitis in critically ill patients: analysis of 3429 catheters from 23 japanese intensive care units","volume":"12","author":"Yasuda","year":"2022","journal-title":"Ann Intensive Care"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102836_bib0017","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1177\/11297298231226426","article-title":"Association between peripheral intravenous catheters and clinical characteristics in the development of phlebitis","volume":"26","author":"Erta\u015f Aky\u00fcz","year":"2025","journal-title":"J Vasc Access"},{"key":"10.1016\/j.hrtlng.2026.102836_bib0018","article-title":"Flebitis zero group. clinical-epidemiological predictors of phlebitis associated with peripheral intravenous catheters in spanish hospitals: results of a national cohort study","volume":"9","author":"Cernuda-Mart\u00ednez","year":"2025","journal-title":"Int J Nurs Stud Adv"},{"issue":"5","key":"10.1016\/j.hrtlng.2026.102836_bib0019","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1017\/ice.2022.87","article-title":"Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 update","volume":"43","author":"Buetti","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"10.1016\/j.hrtlng.2026.102836_bib0020","article-title":"Guidelines for the prevention of intravascular catheter-related infections","volume":"52","author":"O\u2019Grady","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.hrtlng.2026.102836_bib0021","doi-asserted-by":"crossref","first-page":"417","DOI":"10.23938\/ASSN.0975","article-title":"Randomized experimental study to evaluate the effectiveness of the flebitis zero project in Navarre","volume":"44","author":"Ferraz-Torres","year":"2021","journal-title":"An Sist Sanit Navar"},{"issue":"3","key":"10.1016\/j.hrtlng.2026.102836_bib0022","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/j.jhin.2018.06.010","article-title":"Interventions to decrease short-term peripheral venous catheter-related bloodstream infections: impact on incidence and mortality","volume":"100","author":"Saliba","year":"2018","journal-title":"J Hosp Infect"},{"issue":"8","key":"10.1016\/j.hrtlng.2026.102836_bib0023","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/eurjcn\/zvad003","article-title":"Amiodarone-induced phlebitis: incidence and adherence to a clinical practice guideline","volume":"22","author":"Br\u00f8rs","year":"2023","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102836_bib0024","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/jrpp.JRPP_20_11","article-title":"Intravenous drug incompatibilities in the intensive care unit of a tertiary care hospital in India: are they preventable?","volume":"9","author":"Sriram","year":"2020","journal-title":"J Res Pharm Pract"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102836_bib0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0976-0105.134984","article-title":"A clinical study on drug-related problems associated with intravenous drug administration","volume":"5","author":"Vijayakumar","year":"2014","journal-title":"J basic Clin Pharm"},{"issue":"6","key":"10.1016\/j.hrtlng.2026.102836_bib0026","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.enfcli.2009.07.003","article-title":"Incompatibilities in intravenous therapy: what can be done to prevent them?","volume":"19","author":"Secoli","year":"2009","journal-title":"Enferm Clin"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102836_bib0027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/NAN.0000000000000538","article-title":"The prevalence and associated factors of peripheral intravenous complications in a Thai hospital","volume":"47","author":"Kaphan","year":"2024","journal-title":"J Infus Nurs"},{"key":"10.1016\/j.hrtlng.2026.102836_bib0028","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.2147\/JIR.S450149","article-title":"Progress in research on the mechanisms and interventions of phlebitis from the perspective of vascular endothelial cell and signaling pathway","volume":"16","author":"Zhu","year":"2023","journal-title":"J Inflamm Res"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102836_bib0029","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4037\/ccn2019381","article-title":"Phlebitis in intravenous amiodarone administration: incidence and contributing factors","volume":"39","author":"Oragano","year":"2019","journal-title":"Crit Care Nurse"},{"key":"10.1016\/j.hrtlng.2026.102836_bib0030","unstructured":"Flebitis Zero. Flebitis Zero: Buenas pr\u00e1cticas en seguridad de paciente [Technical Report] Oviedo: Flebitis Zero; 2015. [Date of citation: 16 january 2026] Available from: https:\/\/flebitiszero.com\/app\/."},{"issue":"1S Suppl 1","key":"10.1016\/j.hrtlng.2026.102836_bib0031","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/NAN.0000000000000396","article-title":"Infusion therapy standards of practice, 8th edition","volume":"44","author":"Gorski","year":"2021","journal-title":"J Infus Nurs"},{"issue":"7624","key":"10.1016\/j.hrtlng.2026.102836_bib0032","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.hrtlng.2026.102836_bib0033","unstructured":"Flebitis Zero. Protocol for the prevention of phlebitis related to peripheral venous catheters [Technical Report] Oviedo: Flebitis Zero; 2024. [Date of citation: 16 January 2026] Available from: https:\/\/flebitiszero.com\/app\/."},{"issue":"4","key":"10.1016\/j.hrtlng.2026.102836_bib0034","first-page":"68","article-title":"Infection control\u2013a battle in vein: infusion phlebitis","volume":"94","author":"Jackson","year":"1998","journal-title":"Nurs Times."},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102836_bib0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2025-001375","article-title":"Factors associated with: problems of using exploratory multivariable regression to identify causal risk factors","volume":"4","author":"Lewer","year":"2025","journal-title":"BMJ Med"},{"issue":"6","key":"10.1016\/j.hrtlng.2026.102836_bib0036","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1177\/11297298231189963","article-title":"Risk factors and incidence of peripheral venous catheters-related phlebitis between 2017 and 2021: a multicentre study (Flebitis Zero Project)","volume":"25","author":"Cernuda Mart\u00ednez","year":"2024","journal-title":"J Vasc Access"},{"issue":"6","key":"10.1016\/j.hrtlng.2026.102836_bib0037","doi-asserted-by":"crossref","first-page":"10","DOI":"10.22270\/jddt.v13i6.6091","article-title":"High concentration amiodarone continuous infusion induced phlebitis: a case report","volume":"13","author":"Gonenavar","year":"2023","journal-title":"J Drug Deliv Ther"},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102836_bib0038","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40268-020-00329-w","article-title":"Standardization and chemical characterization of intravenous therapy in adult patients: a step further in medication safety","volume":"21","author":"Manrique-Rodr\u00edguez","year":"2021","journal-title":"Drugs R D"},{"issue":"3","key":"10.1016\/j.hrtlng.2026.102836_bib0039","first-page":"132","article-title":"Identification of potentially irritating intravenous medications","volume":"33","author":"Ballesteros-Pe\u00f1a","year":"2022","journal-title":"Enfermer\u00eda Intensiva (English Ed"},{"issue":"8","key":"10.1016\/j.hrtlng.2026.102836_bib0040","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/antibiotics12081338","article-title":"Physicochemical characteristics of antimicrobials and practical recommendations for intravenous administration: a systematic review","volume":"12","author":"Borgonovo","year":"2023","journal-title":"Antibiotics"},{"issue":"7","key":"10.1016\/j.hrtlng.2026.102836_bib0041","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/00365540110080908","article-title":"Antibiotics differ in their tendency to cause infusion phlebitis: a prospective observational study","volume":"34","author":"Lanbeck","year":"2002","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102836_bib0042","doi-asserted-by":"crossref","first-page":"32","DOI":"10.37464\/2013.302.1610","article-title":"Incidence of phlebitis in patients with peripheral intravenous catheters: the influence of some risk factors","volume":"30","author":"Salgueiro-Oliveira","year":"2013","journal-title":"Aust J Adv Nurs"},{"key":"10.1016\/j.hrtlng.2026.102836_bib0043","unstructured":"Salgueiro-Oliveira A., Parreira P., Lima Basto M. Nursing interventions and short peripheral catheter-related phlebitis: systematic literature review. Congress. 13th international nursing research conference abstract book [Abstract Book]. Madrid: Carlos III Health Institute. Coordination and Development Unit for Nursing Research Invest\u00e9n-isciii; 2009:187\u2013190. [Date of citation: 16 January 2026] Available from: http:\/\/hdl.handle.net\/20.500.12105\/18944."},{"issue":"1","key":"10.1016\/j.hrtlng.2026.102836_bib0044","doi-asserted-by":"crossref","first-page":"001","DOI":"10.5606\/fng.btd.2023.23","article-title":"SCOPUS analysis of publications on nursing and phlebitis","volume":"9","author":"Alkan","year":"2023","journal-title":"Demiroglu Sci Univ Florence Nightingale J Med"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102836_bib0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.12788\/jhm.2867","article-title":"Observational study of peripheral intravenous catheter outcomes in adult hospitalized patients: a multivariable analysis of peripheral intravenous catheter failure","volume":"13","author":"Marsh","year":"2018","journal-title":"J Hosp Med"},{"issue":"9\u201310","key":"10.1016\/j.hrtlng.2026.102836_bib0046","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jocn.14760","article-title":"Incidence, severity and risk factors of peripheral intravenous cannula-induced complications: an observational prospective study","volume":"28","author":"Simin","year":"2019","journal-title":"J Clin Nurs"},{"issue":"2","key":"10.1016\/j.hrtlng.2026.102836_bib0047","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/ejhpharm-2022-003294","article-title":"Classification of non-antineoplastic intravenously administered drugs according to their toxicity risk: the path towards safe drug administration","volume":"31","author":"Gim\u00e9nez Poder\u00f3s","year":"2024","journal-title":"Eur J Hosp Pharm"},{"issue":"23\u201324","key":"10.1016\/j.hrtlng.2026.102836_bib0048","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1111\/jocn.13750","article-title":"Prevalence of difficult venous access and associated risk factors in highly complex hospitalised patients","volume":"26","author":"Armenteros-Yeguas","year":"2017","journal-title":"J Clin Nurs"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956326001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956326001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:56:53Z","timestamp":1789091813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956326001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S0147956326001202"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2026.102836","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological burden and chemical phlebitis associated with peripheral venous catheters: A nested case-control study. Results of the national Flebitis Zero project","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2026.102836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102836"}}